Video >> CordenPharma Plankstadt Expanded Highly Potent Development Facility

Mar 30, 2016

Click here to watch a video fo the newly expanded CordenPharma Plankstadt Highly Potent Development facility.

As seen in the press release on March 14, 2016, CordenPharma is pleased to announce the completion and approval of expanded Development Capabilities (CTD2) for mid-scale (up to 20 kg) contained capacity of highly potent and oncology oral dosage forms in its CordenPharma Plankstadt (DE) manufacturing facility. This new and expanded capability provides customers a complete offering in the contained manufacturing of oral dosage from grams to 150 Kg.